Fundz

NRG raises $67 million for a small molecule aimed at Parkinson’s and ALS.

PRIVATESep 08, 2025

Amount Raised

$67 Million

Round Type

Funding Round

StevenageBiotechnologyHealth CareTherapeutics

Investors

Sv Health

Description

NRG has successfully raised $67 million to develop a small molecule targeting Parkinson's disease and ALS. The funding will support the advancement of their innovative treatments. This investment demonstrates confidence in NRG's groundbreaking research. The company aims to make significant strides in neurology with this funding.

Quick answer

NRG Therapeutics raised $67 Million in a Funding Round round, dated September 8, 2025. Investors: Sv Health. NRG Therapeutics is based in Stevenage, England, United Kingdom.

How much did NRG Therapeutics raise?
NRG Therapeutics raised $67 Million in a Funding Round round on September 8, 2025.
Who invested in NRG Therapeutics?
Sv Health is named as investors in this round.
What does NRG Therapeutics do?
NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and..
Where is NRG Therapeutics based and how big is it?
NRG Therapeutics is based in Stevenage, England, United Kingdom.
Who are the decision-makers at NRG Therapeutics?
Fundz holds 1 contact at NRG Therapeutics, including the CEO . Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as NRG Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Acasti raised $4M (Funding Round) on October 23, 2025.
  • ENA Respiratory raised $22M (Series B) on October 22, 2025.
  • Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Valink Therapeutics raised $12M (Pre-Series A) on October 20, 2025.
  • Theriva Biologics raised $13M on October 17, 2025.

Who to call at NRG Therapeutics, and when

A new round usually means NRG Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NRG Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NRG Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NRG Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NRG Therapeutics

Location

Stevenage, England, United Kingdom

About

NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NRG Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNeil M., CEO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NRG Therapeutics's next move

See what Strategic adds

NRG Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.